Section

US FDA approves Genmab-AbbVie’s blood cancer therapy

one year ago Tech inquirer

A PHP Error was encountered

Severity: Warning

Message: getimagesize(https://technology.inquirer.net/files/2023/05/2023-05-19T174749Z_2_LYNXMPEJ4I0PY_RTROPTP_4_INTERCEPT-FDA-NASH-470x313.jpg): Failed to open stream: HTTP request failed! HTTP/1.1 403 Forbidden

Filename: views/amp_news_detail.php

Line Number: 138

Backtrace:

File: /home/moneynations/public_html/application/views/amp_news_detail.php
Line: 138
Function: getimagesize

File: /home/moneynations/public_html/application/controllers/News.php
Line: 132
Function: view

File: /home/moneynations/public_html/index.php
Line: 291
Function: require_once

The United States Food and Drug Administration (FDA) has approved AbbVie Inc and Danish drugmaker Genmab’s blood cancer therapy for adult patients who have received at least two prior lines of treatment, the companies said Friday, May 19. The therapy, epcoritamab, which will be sold under the brand name Epkinly, treats a type of advanced […]

The post US FDA approves Genmab-AbbVie’s blood cancer therapy appeared first on Inquirer Technology.

Read more at: inquirer

Tags : approves genmab abbvie blood cancer therapy

Disclaimer : We make no assurance about the completeness and accuracy of the content of this website. All news on this website is collected from various sources hence information may or may not be true. Bollywood charcha does not verify the reliability of the content published. We do not accept any accountability for loss or damage occurred as a result of reliability on the content of this website.

You May Also Like